Noncoding RNAs in age-related cardiovascular diseases
Detailed Picture VKTX is focused on therapies for the treatment of metabolic and endocrine disorders, with three compounds currently in clinical trials
Mumuni MA, Kenechukwu FC, Ofokansi KC et al (2020) Insulin-loaded mucoadhesive nanoparticles based on mucin-chitosan complexes for oral delivery and diabetes treatment
646,647 Furthermore, the preferential conversion of pyruvate to lactate not only reduces oxidative stress in mitochondria but also regenerates NAD + from NADH, helping to alleviate the electron load and preventing disruption of the ETC caused by excess electrons
Huo H, Peng M, Yu M, Zhang Y, Xiong L, Zhou Q
Tirzepatide: The Next Generation Dual-Action GLP-1 Tirzepatide, approved by the FDA in 2022, represents the newest evolution in GLP-1 technology